PRCT - NASDAQ

PROCEPT BioRobotics Corporation

PRCT·NASDAQ

$26.33

-1.6%

HealthcareMedical - Devices

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.50B

EPS-1.7200

P/E Ratio-15.31

Earnings Date08/05/2026

prct

Other Non-Cash Items

Last Annual Value

433.00K

3-Year CAGR

-56%

5-Year CAGR

28%

10-Year CAGR

Adjust for Inflation

PROCEPT BioRobotics Corporation Competitors Analysis of Other Non-Cash Items

PRCT · NASDAQ

Company	Other Non-Cash Items	CAGR 3Y	CAGR 5Y	CAGR 10Y
PROCEPT BioRobotics Corporation NASDAQ:PRCT	433.00K	-27.0%	N/A	N/A
SS Innovations International, Inc. NASDAQ:SSII	687.28K	-49.4%	-10.3%	N/A
Guardian Pharmacy Services, Inc. NYSE:GRDN	5.43M	0.5%	21.2%	N/A
QuidelOrtho Corporation NASDAQ:QDEL	914.50M	N/A	N/A	68.4%
Twist Bioscience Corporation NASDAQ:TWST	-46.66M	N/A	N/A	N/A
Edgewise Therapeutics, Inc. NASDAQ:EWTX	27.09M	N/A	63.8%	N/A
Artivion, Inc. NYSE:AORT	3.64M	-50.3%	-24.9%	N/A
Clover Health Investments, Corp. NASDAQ:CLOV	-2.53M	N/A	N/A	N/A
Inspire Medical Systems, Inc. NYSE:INSP	133.73M	372.1%	37.9%	93.7%

PROCEPT BioRobotics Corporation Fair Value Envelope

PRCT · NASDAQ

Our analysis suggests that PRCT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $26.33, this represents a potential HIDDEN relative to our calculated worth for PROCEPT BioRobotics Corporation.

HIDDEN

Intrinsic Value

Current Price: $26.33

Related Guides

Blog Categories

Continue your PRCT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.